PROGNOSIS OF PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION, WITH AND WITHOUT VIABLE MYOCARDIUM AFTER MYOCARDIAL-INFARCTION - RELATIVE EFFICACYOF MEDICAL THERAPY AND REVASCULARIZATION
Ks. Lee et al., PROGNOSIS OF PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION, WITH AND WITHOUT VIABLE MYOCARDIUM AFTER MYOCARDIAL-INFARCTION - RELATIVE EFFICACYOF MEDICAL THERAPY AND REVASCULARIZATION, Circulation, 90(6), 1994, pp. 2687-2694
Background The uptake of F-18 deoxyglucose into dysfunctional segments
after myocardial infarction identifies metabolically active (FDG+) or
inactive (FDG-) myocardium. Although patients with FDG+ segments have
been found to be at risk for adverse events, the prognostic significa
nce of viable myocardium in relation to other influences on postinfarc
tion prognosis, including revascularization, remain ill defined. The p
urpose of this study was to investigate the relative prognostic signif
icance of FDG+ tissue and to establish whether myocardial revasculariz
ation in patients with viable tissue attenuates the risk of adverse ou
tcome. Methods and Results One hundred thirty-seven patients with left
ventricular dysfunction and resting perfusion defects after myocardia
l infarction underwent positron emission tomography with both dipyrida
mole stress Rb-82 perfusion imaging and FDG imaging. After the exclusi
on of 4 patients proceeding to transplantation, 2 with uninterpretable
scans and 2 lost to follow-up, 129 patients were followed clinically
for 17+/-9 months. Four groups were defined: patients with FDG+ dysfun
ctional myocardium who were revascularized (n=49) or treated medically
(n=21) and those with FDG-segments who were revascularized (n=19) or
treated medically (n=40). The groups of patients with FDG+ or FDG- fin
dings, with and without revascularization, did not differ with respect
to known determinants of postinfarction prognosis: age, left ventricu
lar ejection fraction, or the prevalence of multivessel disease. Nonfa
tal ischemic events occurred in 48% of medically treated FDG+ patients
compared with 8% of revascularized patients with FDG+ tissue (P<.001)
and 5% of patients with FDG- myocardium (P<.001). Thirteen patients d
ied from cardiac causes; 11 (85%) had a left ventricular ejection frac
tion of <30%, and these patients were evenly distributed between FDGand FDG- groups. Using Cox's proportional hazards model, only the pres
ence of FDG+ myocardium (odds ratio, 12.9; P<.001) and the absence of
revascularization (odds ratio, 5.8; P=.002) independently predicted is
chemic events, while only age (P=.02) and ejection fraction (P<.001) b
ut not the presence of viable myocardium were predictive of death. Con
clusions Residual viable myocardium after myocardial infarction may ac
t as an unstable substrate for further events unless it is revasculari
zed. Despite this association, age and left ventricular dysfunction re
mained the strongest predictors of cardiac death after myocardial infa
rction in these patients with a spectrum of left ventricular dysfuncti
on.